129 related articles for article (PubMed ID: 2876925)
1. Oncogene alterations in primary human colon tumors.
Alexander RJ; Buxbaum JN; Raicht RF
Gastroenterology; 1986 Dec; 91(6):1503-10. PubMed ID: 2876925
[TBL] [Abstract][Full Text] [Related]
2. Oncogene alterations in rat colon tumors induced by N-methyl-N-nitrosourea.
Alexander RJ; Buxbaum JN; Raicht RF
Am J Med Sci; 1992 Jan; 303(1):16-24. PubMed ID: 1728873
[TBL] [Abstract][Full Text] [Related]
3. Determination of cellular oncogene rearrangement or amplification in ovarian adenocarcinomas.
Smith DM; Groff DE; Pokul RK; Bear JL; Delgado G
Am J Obstet Gynecol; 1989 Oct; 161(4):911-5. PubMed ID: 2801838
[TBL] [Abstract][Full Text] [Related]
4. Genetic alterations of c-myc, c-erbB-2, and c-Ha-ras protooncogenes and clinical associations in human breast carcinomas.
Garcia I; Dietrich PY; Aapro M; Vauthier G; Vadas L; Engel E
Cancer Res; 1989 Dec; 49(23):6675-9. PubMed ID: 2573420
[TBL] [Abstract][Full Text] [Related]
5. K-RAS point mutation, and amplification of C-MYC and C-ERBB2 in colon adenocarcinoma.
Kruszewski W; Kowara R; Rzepko R; Warezak C; Zieliński J; Gryglewski G; Kopacz A; Jastrzebski T; Pawełczyk T
Folia Histochem Cytobiol; 2004; 42(3):173-9. PubMed ID: 15493579
[TBL] [Abstract][Full Text] [Related]
6. Deregulation of c-myc gene expression in human colon carcinoma is not accompanied by amplification or rearrangement of the gene.
Erisman MD; Rothberg PG; Diehl RE; Morse CC; Spandorfer JM; Astrin SM
Mol Cell Biol; 1985 Aug; 5(8):1969-76. PubMed ID: 3837853
[TBL] [Abstract][Full Text] [Related]
7. H-ras protooncogene mutations in human thyroid neoplasms.
Namba H; Gutman RA; Matsuo K; Alvarez A; Fagin JA
J Clin Endocrinol Metab; 1990 Jul; 71(1):223-9. PubMed ID: 2196280
[TBL] [Abstract][Full Text] [Related]
8. Amplification of protooncogenes in surgical specimens of human lung carcinomas.
Shiraishi M; Noguchi M; Shimosato Y; Sekiya T
Cancer Res; 1989 Dec; 49(23):6474-9. PubMed ID: 2573414
[TBL] [Abstract][Full Text] [Related]
9. Novel combination of c-myc, N-myc and N-ras oncogene alteration in brain tumors.
Sauceda R; Ocadiz R; Gutierrez AL; Salcedo M; Ortega V; Figueroa HH; Gariglio P
Brain Res; 1988 Apr; 427(2):123-32. PubMed ID: 2838125
[TBL] [Abstract][Full Text] [Related]
10. Proto-oncogene allelic variations in human squamous cell carcinomas of the larynx.
Dolcetti R; Pelucchi S; Maestro R; Rizzo S; Pastore A; Boiocchi M
Eur Arch Otorhinolaryngol; 1991; 248(5):279-85. PubMed ID: 1679639
[TBL] [Abstract][Full Text] [Related]
11. Designed diagnostic restriction fragment length polymorphisms for the detection of point mutations in ras oncogenes.
Kumar R; Dunn LL
Oncogene Res; 1989; 4(3):235-41. PubMed ID: 2567980
[TBL] [Abstract][Full Text] [Related]
12. Rapid detection of ras oncogenes in human tumors: applications to colon, esophageal, and gastric cancer.
Jiang W; Kahn SM; Guillem JG; Lu SH; Weinstein IB
Oncogene; 1989 Jul; 4(7):923-8. PubMed ID: 2666911
[TBL] [Abstract][Full Text] [Related]
13. In vivo amplification and rearrangement of c-myc oncogene in human breast tumors.
Bonilla M; Ramirez M; Lopez-Cueto J; Gariglio P
J Natl Cancer Inst; 1988 Jul; 80(9):665-71. PubMed ID: 3373555
[TBL] [Abstract][Full Text] [Related]
14. Oncogene amplifications, rearrangements, and restriction fragment length polymorphisms in human leukaemia.
Boehm TL; Hirth HP; Kornhuber B; Drahovsky D
Eur J Cancer Clin Oncol; 1987 Jun; 23(6):623-9. PubMed ID: 2888656
[TBL] [Abstract][Full Text] [Related]
15. Nuclear oncogene amplification or rearrangement is not involved in human colorectal malignancies.
Dolcetti R; De Re V; Viel A; Pistello M; Tavian M; Boiocchi M
Eur J Cancer Clin Oncol; 1988 Aug; 24(8):1321-8. PubMed ID: 3181252
[TBL] [Abstract][Full Text] [Related]
16. Association of genetic alterations of c-myc, c-fos, and c-Ha-ras proto-oncogenes in colorectal tumors. Frequency and clinical significance.
Nagai MA; Habr-Gama A; Oshima CT; Brentani MM
Dis Colon Rectum; 1992 May; 35(5):444-51. PubMed ID: 1373678
[TBL] [Abstract][Full Text] [Related]
17. Colon carcinoma K-ras 2 oncogene of a familial polyposis coli patient.
Yuasa Y; Oto M; Sato C; Miyaki M; Iwama T; Tonomura A; Namba M
Jpn J Cancer Res; 1986 Sep; 77(9):901-7. PubMed ID: 3021699
[TBL] [Abstract][Full Text] [Related]
18. Oncogene amplification in squamous cell carcinoma of the oral cavity.
Saranath D; Panchal RG; Nair R; Mehta AR; Sanghavi V; Sumegi J; Klein G; Deo MG
Jpn J Cancer Res; 1989 May; 80(5):430-7. PubMed ID: 2502519
[TBL] [Abstract][Full Text] [Related]
19. [Amplification of myc-specific sequences in human colonic cancer].
Serova OM; Shpatar' TV; Fedorov SN; Kniazev PG; Novikov LB
Vopr Onkol; 1986; 32(8):89-92. PubMed ID: 3765514
[TBL] [Abstract][Full Text] [Related]
20. Prognostic implications of expression of the cellular genes myc, fos, Ha-ras and Ki-ras in colon carcinoma.
Monnat M; Tardy S; Saraga P; Diggelmann H; Costa J
Int J Cancer; 1987 Sep; 40(3):293-9. PubMed ID: 3040597
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
